$PTGX

Protagonist Therapeutics, Inc. (PTGX) presented at the Barclays 28th Annual Global Healthcare Conference, highlighting advancements in its clinical pipeline. The company's discussions included progress on treatments for autoimmune diseases and hematologic disorders, which represent significant market opportunities. PTGX emphasized data supporting its lead product candidates, which investors had been eagerly anticipating. The presentation showcased strong potential for future growth, attracting interest from both institutional and retail investors. Overall, the company continues to build momentum as it approaches key clinical milestones.